Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network (PanCAN) leads the way in accelerating critical progress for pancreatic cancer patients. PanCAN takes bold action by funding life-saving research, providing personalized patient services and creating a community of supporters and volunteers who will stop at nothing to create a world in which all pancreatic cancer patients will thrive.

Latest from Pancreatic Cancer Action Network

The Importance of Precision Medicine: The Next Frontier in Treatment

September 25, 2024

Article

Patrick Swayze’s Widow Reflects His Cancer, Demi Moore Speaks About Breast Cancer and More

April 12, 2024

Article

From Patrick Swayze’s widow recalling his pancreatic cancer diagnosis to Demi Moore speaking about her aunt’s courage during cancer, here’s what’s going on in the oncology space this week.

U.S. HOUSE OF REPRESENTATIVES SUPPORTS $20 MILLION FOR PANCREATIC CANCER RESEARCH FUNDING

September 29, 2023

Article

With Leadership from Pancreatic Cancer Action Network (PanCAN) Champions in Congress, House Defense Appropriations Bill Passes with Increase to Pancreatic Cancer Research Program at Department of Defense.

THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS

September 26, 2023

Article

Innovative Multimillion-Dollar Grant Was Created in 2022 to Drive Biopharma Industry to Speed Development of Pancreatic Cancer Therapies.

Ativan Associated With Worse Survival For Patients With Pancreatic Cancer

August 31, 2023

Article

Researchers found that patients with pancreatic cancer receiving chemotherapy saw worse survival outcomes when taking Ativan, commonly prescribed to treat anxiety. What other mental health options are available?

PANCREATIC CANCER ACTION NETWORK ANNOUNCES RECORD-BREAKING ANNUAL RESEARCH INVESTMENT, INCLUDING NEW GRANT AWARDS, WHICH WILL ACCELERATE PROGRESS AGAINST PANCREATIC CANCER

August 30, 2023

Article

PanCAN Has Invested More Than $208 Million Over 20 Years Aimed at Building the Field of Pancreatic Cancer Researchers and Finding More Breakthroughs for Patients.